Alembic Pharmaceuticals Limited — Others, 28-06-2025: Disclosure under SEBI Takeover Regulations

Alembic Pharmaceuticals has declared that neither it nor its promoters and persons acting in concert have created any encumbrance on the company’s shares during the financial year 2024-25. This assurance signals stability in the shareholding pattern and indicates that the promoter group continues to hold an unencumbered stake, which is generally positive for shareholder confidence and reflects the promoters’ commitment to maintaining a clean ownership structure.